Literature DB >> 18194279

Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.

V Strugala1, P W Dettmar, J P Pearson.   

Abstract

BACKGROUND: The colon is covered by a mucus barrier that protects the underlying mucosa and alterations in this mucus barrier have been implicated in the aetiology of inflammatory bowel disease (IBD). This study investigated the thickness and continuity of the mucus barrier in ulcerative colitis (UC) and Crohn's disease (CD) in comparison to normal controls.
METHODS: Rectal biopsies were taken from 59 patients and cryostat sections stained with periodic acid-Schiff's/Alcian blue to visualise the mucus layer. Mucus thickness and continuity and goblet cell density were measured using light microscopy.
RESULTS: An essentially continuous adherent mucus layer was observed in normal human rectum and there was no change in the mucus barrier in quiescent UC. In active UC there was a trend for the mucus layer to become progressively thinner and significantly more discontinuous as disease severity increased. In severe active UC the mucus layer thickness and goblet cell density were significantly reduced compared with normal controls while the percentage discontinuity significantly increased.
CONCLUSION: It is not until severe UC that there is a global change in mucosal protection as a consequence of large regions lacking mucus, a decrease in secretory potential caused by a loss of goblet cells and a thinner, less effective mucus layer even when it is present.

Entities:  

Mesh:

Year:  2008        PMID: 18194279     DOI: 10.1111/j.1742-1241.2007.01665.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  59 in total

1.  Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Authors:  Sufeng Zhang; Won Joon Cho; Amy T Jin; Lie Yun Kok; Yunhua Shi; David E Heller; Young-Ah Lucy Lee; Yixuan Zhou; Xi Xie; Joshua R Korzenik; Jochen K Lennerz; Giovanni Traverso
Journal:  Adv Healthc Mater       Date:  2020-06-29       Impact factor: 9.933

2.  An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants.

Authors:  Jenny K Gustafsson; Anna Ermund; Malin E V Johansson; André Schütte; Gunnar C Hansson; Henrik Sjövall
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-08       Impact factor: 4.052

3.  Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.

Authors:  Roni Nowarski; Ruaidhrí Jackson; Nicola Gagliani; Marcel R de Zoete; Noah W Palm; Will Bailis; Jun Siong Low; Christian C D Harman; Morven Graham; Eran Elinav; Richard A Flavell
Journal:  Cell       Date:  2015-12-03       Impact factor: 41.582

4.  Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiota.

Authors:  Philip Smith; Jay Siddharth; Ruth Pearson; Nicholas Holway; Mark Shaxted; Matt Butler; Natalie Clark; Joanna Jamontt; Robert P Watson; Devika Sanmugalingam; Scott J Parkinson
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

5.  In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy.

Authors:  Hao Ding; Andrew W Dupont; Shashideep Singhal; Larry D Scott; Sushovan Guha; Mamoun Younes; Xiaohong Bi
Journal:  Biomed Opt Express       Date:  2017-06-23       Impact factor: 3.732

6.  Microbiota-nourishing Immunity and Its Relevance for Ulcerative Colitis.

Authors:  Mariana X Byndloss; Yael Litvak; Andreas J Bäumler
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

7.  Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain.

Authors:  Yves-Marie Coïc; Francoise Baleux; Ömer Poyraz; Roman Thibeaux; Elisabeth Labruyere; Fabrice Chretien; Iradj Sobhani; Thierry Lazure; Benjamin Wyplosz; Gunter Schneider; Laurence Mulard; Philippe J Sansonetti; Benoit S Marteyn
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

Review 8.  Molecular pathways driving disease-specific alterations of intestinal epithelial cells.

Authors:  Rocío López-Posadas; Markus F Neurath; Imke Atreya
Journal:  Cell Mol Life Sci       Date:  2016-09-13       Impact factor: 9.261

9.  Stimulatory role of PKCalpha in extracellular regulated kinase 1/2 pathway in conjunctival goblet cell proliferation.

Authors:  Marie A Shatos; Robin R Hodges; Jeffrey A Bair; Kameran Lashkari; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

10.  Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions.

Authors:  Rodrigo Bibiloni; Eduardo J Schiffrin
Journal:  Int J Inflam       Date:  2010-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.